Form 4 for RLMD RELMADA THERAPEUTICS, INC.
Accepted 2021-08-19 00:00:00 ET · period of report 2021-08-17 · accession 0001213900-21-043907 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-19 | 2021-08-17 | RLMD | CASAMENTO CHARLES J | Dir | M - OptEx | $4.60 | +10.0K | 14.7K | +213% | +$46.0K |
| D | 2021-08-19 | 2021-08-17 | RLMD | CASAMENTO CHARLES J | Dir | M - OptEx | $0.00 | -10.0K | 102.5K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-17 | M | A | 10,000 | $4.60 | 14,700 | D | — | — | |
| 2 | Derivative | Options to purchase common stock | 2021-08-17 | M | D | 10,000 | $0.00 | 102,500 | D | $4.60 · 2018-12-20 to 2028-12-20 | 10,000 Common Stock | (F2) Not applicable. (F1) The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period. |